Aurobindo Pharma Q3 Results: Net profit drops 19% YoY to Rs 491 crore
We witnessed an improved momentum backed by recovery across our business verticals and our endeavor is to continuously innovate and differentiate,” said K. Nithyananda Reddy, vice-chairman and managing director of Aurobindo Pharma
